Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's What You Should Know

Group 1 - Foghorn Therapeutics Inc. (FHTX) closed at $5.06, with a 1.4% gain over the past four weeks, and a mean price target of $11.67 suggests a 130.6% upside potential [1] - The average of six short-term price targets ranges from $9.00 to $14.00, indicating a potential increase of 77.9% to 176.7%, with a standard deviation of $2.25 reflecting the variability of estimates [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as the Zacks Consensus Estimate for the current year has increased by 8% [4][12] Group 2 - FHTX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While price targets may not be reliable indicators of actual stock price movements, the direction implied by these targets can serve as a useful guide for further research [14]